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The periodontal pathogen Tannerella forsythia expresses several glycosidases which are 3 
linked to specific growth requirements and are involved in the invasion of host tissues. g-L-4 
fucosyl residues are exposed on various host glycoconjugates and, thus, the g-L-fucosidases 5 
predicted in the T. forsythia ATCC 43037 genome could potentially serve roles in host-6 
pathogen interactions. We describe the molecular cloning and characterization of the putative 7 
fucosidase TfFuc1 (encoded by the bfo_2737 = Tffuc1 gene), previously reported to be 8 
present in an outer membrane preparation. In terms of sequence, this 51-kDa protein is a 9 
member of the glycosyl hydrolase family GH29. Using an artificial substrate, p-nitrophenyl-10 
g-fucose (KM 670 µM), the enzyme was determined to have a pH optimum of 9.0 and to be 11 
competitively inhibited by fucose and deoxyfuconojirimycin. TfFuc1 was shown here to be a 12 
unique g(1,2)-fucosidase that also possesses g(1,6) specificity on small unbranched substrates. 13 
It is active on mucin after sialidase-catalysed removal of terminal sialic acid residues and also 14 
removes fucose from blood group H. Following knock-out of the Tffuc1 gene and analysing 15 
biofilm formation and cell invasion/adhesion of the mutant in comparison to the wild-type, it 16 
is most likely that the enzyme does not act extracellularly. Biochemically interesting as the 17 
first fucosidase in T. forsythia to be characterized, the biological role of TfFuc1 may well be 18 
in the metabolism of short oligosaccharides in the periplasm, thereby indirectly contributing 19 
to the virulence of this organism. TfFuc1 is the first glycosyl hydrolase in the GH29 family 20 
reported to be a specific g(1,2)-fucosidase. 21 





Tannerella forsythia is a Gram-negative anaerobic oral pathogen, a member of the so-called 3 
“red complex” of bacteria that cause a set of inflammatory diseases named periodontitis, 4 
affecting millions of people worldwide.1-3 The effects on the periodontium include loss of the 5 
alveolar bone around the teeth, swelling and bleeding of the gum and, in more severe cases, 6 
loss of teeth. Periodontitis has also been linked to systemic inflammation and to an increased 7 
risk of stroke, heart attacks and atherosclerosis, amongst others.4 8 
 Like other bacteria residing in human hosts, T. forsythia has adapted to better suit its 9 
niche with cell surface glycosylation thought to be key to this adaptation.5 As previously 10 
described, T. forsythia cells are completely covered by a unique surface (S-) layer formed by 11 
co-assembly of two different proteins both of which are highly O-glycosylated with an 12 
equally unique glycan.6-8 Mutant strains lacking either the S-layer or glycan assembly and 13 
maturation genes, display phenotypes involving altered human cell attachment to host cells, 14 
biofilm formation, and disease progression.9-11 In addition, the structure of the glycan partially 15 
imitates that of host glycoproteins, having a terminal sialic acid-like residue (precisely, a 16 
modified pseudaminic acid residue) and a terminal fucose, with the latter shown to be present 17 
in substoichiometric amounts and linked to a methylated galactose in an unknown glycosidic 18 
linkage.8 The glycobiology of this pathogen, including its repertoire of glycosidases, seems to 19 
be key to its physiology and, potentially, its pathogenicity.5, 12  20 
Recent evidence suggests that for several periodontal pathogens, but particularly for 21 
the “red complex” organism T. forsythia, sialic acid-containing host molecules play an 22 
important role in vivo.13 Two different sialidases have been found in T. forsythia, SiaHI and 23 
NanH. In the case of SiaHI, its function is unclear. It is not a canonical sialidase (i.e., not in 24 
the GH35 family), a siaH1 mutant has no discernible phenotype, and experiments point to it 25 
being a periplasmic protein without any role in extracellular interactions.14 These same studies 26 
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also indicated that mutants lacking the main T. forsythia sialidase NanH had hindered 1 
attachment and invasion of human oral epithelial cells. The enzyme was also seen to play an 2 
important role in biofilm growth on surfaces coated with salivary glycoproteins.15 The nanH 3 
gene is located in a large cluster that contains all the genes required for sialic acid catabolism, 4 
which indicates that the cleaved sialic acid can additionally be taken up and utilized.12, 13 This 5 
gene cluster also contains a く-hexosaminidase that may cleave sub-terminal residues after 6 
sialidase action and may also play a role in vivo.15 Additionally, in a separate study, 7 
transcriptome analysis of the oral microbiome also showed up-regulation of the sialidase 8 
nanH mRNA in dental plaque.16 9 
g-L-fucosyl residues are, like sialic acid, frequently located at a terminal position on 10 
various host glycoconjugates including blood groups, milk oligosaccharides, gastric and 11 
submaxillary mucin, and serum glycoproteins.17, 18 Therefore, fucosidases in T. forsythia 12 
could potentially play similar roles to sialidases.19 It has generally been shown that terminal 13 
fucose residues play important roles in mammalian cell-cell communication and also in their 14 
interaction with pathogenic bacteria; for instance, Campylobacter jejuni and Helicobacter 15 
pylori are known to bind certain fucosylated blood groups (e.g., O-antigen) in order to 16 
mediate infection.19-21 In addition, the ability to utilize available fucose provides many 17 
bacteria with a nutritional advantage and contributes to survival in a highly competitive 18 
ecosystem, such as the human body.22, 23 19 
Characterization of g-L-fucosidases in T. forsythia could aid in the elucidation of the 20 
structure-function relationship of fucosylated host and bacterial surfaces in the virulence of 21 
oral pathogens. The genome of T. forsythia encodes three putative g-L-fucosidases, 22 
BFO_2737 and BFO_1182, both classified in the CAZy (Carbohydrate Active enZymes; 23 
http://www.cazy.org/) glycosyl hydrolase family GH29, and BFO_3101, classified in family 24 
GH95. While all three enzymes possess a glycosyl hydrolase domain and are classified by 25 
CAZy according to their mechanism of action, BFO_1182 and BFO_3101 are not strictly 26 
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annotated as g-L-fucosidases but as a F5/8 type C domain protein and a putative lipoprotein, 1 
respectively. 2 
Here, we describe the molecular cloning and characterization of BFO_2737, which we 3 
named TfFuc1. This protein has previously been reported to form part of an outer membrane 4 
preparation of T. forsythia 24 and, thus, was a good candidate to be involved in host-pathogen 5 
interactions. TfFuc1 is a 446-amino acid protein with a theoretical pI and molecular mass of 6 
6.9 and 50.8 kDa, respectively. It is the first fucosidase in this organism to be characterized to 7 
date. The enzyme was shown here to be an g(1,2)-fucosidase and also possesses an g(1,6) 8 
specificity on small unbranched substrates. It is a predicted periplasmic protein, possibly 9 
playing a role in the breakdown of small oligosaccharides. It is, to the best of our knowledge, 10 




Enzymatic characterization of rTfFuc1. The Tffuc1 gene was cloned into pET22-b(+) 15 
vector and expressed in E. coli as a C-terminally His6-tagged protein, which enabled 16 
purification via nickel affinity chromatography (Fig. 1). The enzymatic activity was then 17 
tested using the standard colorimetric g-fucosidase substrate 4-nitrophenyl-g-L-18 
fucopyranoside (pNP-fucose) at 22°C in a range of different pH values and in the presence of 19 
MgCl2, KCl and NaCl, in order to establish its pH optimum and cation dependence, 20 
respectively. By stopping the reaction with the addition of an alkaline buffer at pH 11.4, it 21 
was ensured that all wells where at the same pH for consequent absorbance readings. The 22 
activity of the enzyme was seen to start to plateau at the neutral to alkaline pH range and was 23 
considered most active at pH 9.0, assayed in glycine buffer, and not at pH 9.25 where the 24 
activity suddenly peaks and then rapidly decreases thereafter. The activity remained largely 25 
unaffected by the presence of cations at the two concentrations tested (results not shown). The 26 
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KM and Vmax catalytic constants at 22°C, calculated from the activity of the enzyme at 1 
different pNP-fucose concentrations, were 670 µM and 20.4 µmol/min (U) per mg of protein, 2 
respectively (Table 1). The determined catalytic constants for rTffuc1 are in the range of 3 
those reported for other fucosidases/ glycosylhydrolases when tested on their corresponding 4 
pNP-substrates.25-27 5 
 6 
Substrate linkage specificity of rTfFuc1. To determine the enzyme linkage specificity, 7 
rTfFuc1 was incubated with a set of different fucosylated substrates of defined structure 8 
representing a range of fucose linkages available on host glycoproteins and on oral surfaces 9 
(Fig. 3). The reaction products obtained after overnight incubation were analysed using high-10 
pH anion-exchange chromatography with pulsed amperometric detection (HPAEC) where the 11 
release of fucose was confirmed by comparison with the retention time of the standard 12 
monosaccharide and of a substrate standard after overnight incubation at 37°C. The enzyme 13 
was seen to be active on both g(1,2) fucose containing substrates, 2-fucosyllactose and H-14 
trisaccharide, and on the g(1,6) fucose disaccharide g-L-Fuc-(1,6)-く-D-GlcNAc, although this 15 
latter reaction did not reach completion, indicating weak specificity for this linkage. The 16 
g(1,3) and g(1,4) linkages were not cleaved on 3-fucosyllactose and the Lewis A 17 
trisaccharide, respectively. The enzyme was also inactive on the substrate g-L-Fuc-(1,4)-く-D-18 
Gal, added as a second disaccharide control to prove that the g(1,6) activity was not due to 19 
differences in substrate length (Fig. 4). 20 
 In order to obtain accurate activity values on the cleaved substrates, the K-FUCOSE 21 
kit from Megazyme was used, coupled to the enzymatic reaction with rTfFuc1. First, FDH, 22 
which also has an alkaline pH optimum, and NADP+ were added to the substrate solution 23 
reaction mixture in order to convert any free fucose already present in the sample to L-fucono-24 
1,5-lactone by the reduction of NADP+ to NADPH (ε340 = 6.022 mM-1cm-1). rTfFuc1 was then 25 
added to the mixture and the reaction was monitored by following the increase in Abs340. The 26 
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activity was calculated from where the formation of NADPH was linear over time. The 1 
enzyme was most active on 2-fucosyllactose and H-trisaccharide with specific activities of 2 
0.8 U/mg and 0.6 U/mg, respectively. The activity on the g(1,6) disaccharide was 3 
significantly lower at 0.35 U/mg (Table 2). 4 
 The activity of the enzyme on the various substrates could be calculated 5 
approximately (as some loss of material occurred during sample preparation) from the HPLC 6 
experiments after 1-h incubation periods (results not shown) and was found to be markedly 7 
lower than that observed with the K-FUCOSE kit, indicating that free fucose, which is 8 
consumed in the latter, could be inhibiting the enzymatic activity significantly. In order to 9 
determine the extent of such an effect, measurement of KM and Vmax values were repeated 10 
with pNP-fucose in the presence of either 0.25 mM L-fucose or 0.1 µM deoxyfuconojirimycin 11 
(DFJ), which is a strong fucosidase inhibitor.28 The enzyme was competitively inhibited by 12 
both fucose and DFJ as the Vmax remained largely unaffected but the KM value increased from 13 
0.67 mM to 16.5 mM and 28.3 mM, respectively (Table 1). 14 
 Further, the ability of the enzyme to cleave fucose residues off more complex 15 
natural glycans and those on branched sugar residues was assayed (compare with Fig. 3). As 16 
expected, the enzyme was unable to cleave the g(1,3) fucose linkage on GalFGalF-pep, 17 
included in the assays as a trace amount of activity could be observed when using 3-18 
fucosyllactose, as measured by the K-FUCOSE kit. The enzyme was also not able to cleave 19 
the core g-1,6 fucose linkage on GnGnF6-pep nor the branched g(1,2)-linked fucose on the 20 
A antigen. The non-branched g(1,2) fucose linkage present on the Eastern oyster substrate, 21 
however, was cleaved off the substrate GalF, seen by the loss of a fucose residue in the MS 22 
spectra of the substrate. The major m/z 1703 glycan ([M+H]+) was approximately 50% 23 
digested to a defucosylated species of m/z 1557 after overnight incubation with the enzyme 24 
(Fig. 5). The enzyme is, therefore, able to cleave off fucose residues which are g(1,2) linked 25 
on more complex glycans only when in a terminal unbranched position and is unable to cleave 26 
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core g(1,6) fucose. This data supports that the enzyme acts as an g(1,2) fucosidase. 1 
 2 
rTfFuc1 activity on bovine submaxillary mucin. rTfFuc1 was incubated with mucin from 3 
bovine submaxillary glands and the release of fucose was measured with the K-FUCOSE kit. 4 
Incubation was performed also in combination with rNanH from T. forsythia and activities 5 
were calculated from the slope of 〉Abs340 where it was linear over time. During the assayed 6 
incubation period of 10 min, no activity could be detected when rTfFuc1 was incubated alone 7 
with mucin. The 〉Abs340 lead to an irregular data set with a very low r2 value. However, 8 
fucose release was detectable when the incubation was performed in conjunction with the 9 
rNanH sialidase, presenting a slow but steady increase in the Abs340. The activity was 10 
calculated over a period of 300 s where the data points fitted a linear regression with an r2 of 11 
0.98 (Fig. 6). The experiment was repeated several times and yielded an activity of 24 12 
±4 mU/mg. rTfFuc1 might cleave fucose off mucin over longer periods of time, but the data 13 
shows a significantly higher activity when sialic acid residues are first removed from mucin, 14 
indicating that the fucosidase TfFuc1 could work downstream from the sialidase in T. 15 
forsythia and presumably cooperate with other glycosidases in the degradation of complex 16 
glycans. 17 
 18 
Cellular localization of TfFuc1. TfFuc1 was previously reported to be present in the outer 19 
membrane fraction of T. forsythia.24 In an effort to investigate its presence on the surface of T. 20 
forsythia cells, TfFuc1-specific polyclonal antiserum was raised against the recombinant 21 
enzyme in mice and used for Western immunoblotting of cellular fractions separated by SDS-22 
PAGE. Protein visualization by CBB staining showed good separation between the fractions, 23 
as the S-layer bands were very prominent in the outer membrane fraction but not in the inner-24 
membrane and non-membrane associated fractions. Western immunoblotting showed that all 25 
the detectable TfFuc1 fucosidase was found in the non-membrane associated fraction 26 
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comprising both the cytoplasmic and periplasmic content (Fig. 7), arguing against surface 1 




Colonization of the periodontal pocket by the pathogenic late colonizer T. forsythia depends 6 
largely on pre-existing bacteria that have already tipped the oral balance away from health 7 
and towards disease.29 Factors such as a pH shift from neutral to alkaline and slight raises in 8 
the temperature due to the host inflammatory response could be contributing factors favouring 9 
the process.30 In a situation of oral disease, the number of different bacteria living in the 10 
gingival crevice decreases markedly due to putative pathogenic bacteria being more 11 
competitive in such an environment.31 It is in these conditions that T. forsythia seems to thrive 12 
and becomes one of the key players in severe cases of periodontitis. 13 
 The NanH sialidase in T. forsythia has been well established to play important roles 14 
in adherence to sialylated glycoprotein-coated surfaces and epithelial cells in addition to 15 
triggering biofilm growth and being up-regulated in dental plaque.14-16 As the other important 16 
terminal sugar on host glycoproteins is fucose, here, we performed an initial characterization 17 
of a putative g-L-fucosidase encoded in the T. forsythia genome, product of the gene Tffuc1, 18 
previously reported to be part of the outer membrane proteome.24 19 
 By producing the enzyme recombinantly in E. coli we were able to show that the 20 
enzyme is active across a broad pH range from 7.0-9.0, having an unusually high pH optimum 21 
of 9.0. It presents a unique g(1,2)-linkage specificity on terminal non-branched fucose 22 
residues, being also active on small non-branched g(1,6) fucosylated substrates. Whilst both 23 
these linkages are cleaved at a considerable rate in the case of small linear substrates, the 24 
g(1,6) specificity is not detected on core fucoses on more complex glycopeptides. The g(1,2) 25 
linkage specificity was apparent on both small linear substrates, such as 2-fucosyllactose and 26 
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H-trisaccharide, and on more complex glycans only when fucose occupied a terminal 1 
position, but not on a branched substrate where the fucose residue is linked to a fully 2 
substituted sugar. The enzyme seems to be, to the best of our knowledge, the first fucosidase 3 
in its GH family (GH29) to have a specific g(1,2) activity. The broad, high pH activity profile 4 
of this fucosidase ties in with its physiological niche which is known to have a pH that rises as 5 
periodontal disease progresses.30 The possession of such enzymes with higher activities in 6 
alkaline surroundings could contribute to competiveness and virulence of T. forsythia in a 7 
diseased environment.  8 
 During the course of this study, it became clear that one of the issues possibly 9 
underlining our observations was the enzyme’s cellular localization. Even though TfFuc1 was 10 
found previously to be present in the outer membrane proteome of the pathogen,24 localization 11 
of the enzyme on the surface of T. forsythia cells by fluorescent immunolabelling was not 12 
successful (data not shown; see Experimental Procedures in the Supplementary Information) 13 
and cell fractionation also showed the detectable protein to be found in the non-membrane 14 
associated fraction (Fig. 7). This would be in agreement with bioinformatics interrogation 15 
indicating that, while it has a Sec-dependent secretion signal (as predicted by SignalP 4.1 16 
Server), it is not predicted to reside in the outer membrane or be secreted, nor does it contain a 17 
T9SS C-terminal secretion signal.32 The difference in location of TfFuc1 between the present 18 
study and the outer membrane proteomics experiment24 can be reconciled when considering 19 
that in the latter study, cross-contamination of individual proteins between cellular fractions 20 
was not investigated. 21 
 Incubation of the recombinant fucosidase with bovine submaxillary mucin showed 22 
no detectable release of fucose over an incubation period of 10 min. Activity on this complex 23 
substrate could only be detected when the incubation was performed in combination with the 24 
recombinant NanH sialidase from T. forsythia. It is, therefore, conceivable that TfFuc1 could 25 
play an accompanying role to the sialidase in the interaction between T. forsythia and host 26 
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glycoproteins, but given its periplasmic location, this could merely reflect the need for 1 
removal of terminal sialic acid residues for the enzyme to work, either indicating that it most 2 
likely acts on internalised fucosyl substrates after sialic acid has already been removed by the 3 
action of sialidases or, less likely, that it acts in concert with sialidases externally. 4 
 This notion that the T. forsythia fucosidase TfFuc1 plays an internal role was 5 
corroborated when we tested the effect of the ∆Tffuc1 mutation on the ability of T. forsythia to 6 
interact with and invade human oral epithelial cells using an antibiotic protection assay on the 7 
oral epithelial cell line H357.33 We found no significant differences in the ability of the 8 
∆Tffuc1 to invade these human cells as compared to the WT strain (Fig. S1), indicating that 9 
TfFuc1 has no effect on epithelial cell-invasion under the conditions tested. In addition, the 10 
mutant did not show hindered biofilm formation when cultured on bovine submaxillary 11 
mucin, contrary to the T. forsythia NanH sialidase mutant,15 but showed a slightly increased 12 
biofilm formation (Fig. S2). 13 
 Our data supports the idea of a periplasmic fucosidase involved in the final 14 
breakdown of small substrates that have been internalized, possibly owing to the action of 15 
exoglycosidases and endoglycosidases which break-down larger glycans on the outside of the 16 
cell.34, 35 TfFuc1 would possibly then be able to exert its full potential freeing both g(1,2) and 17 
g(1,6) fucoses on small linear substrates. These findings are also in agreement with the 18 
hypothesis that the fucosidase acts downstream of the sialidases, which have been shown to 19 
act on whole glycoproteins on bacterial and host surfaces.14, 15, 36 The sialic acid would, 20 
therefore, already be missing as smaller parts of the glycan are transported inside the cell. 21 
 T. forsythia has no straightforwardly identifiable fucose catabolism locus in its 22 
genome, nor does it have the bifunctional L-fucokinase/GDP-fucose pyrophosphorylase 23 
required normally for Bacteroidetes to recycle the fucose into its glycans.23 In an effort to see 24 
the effect on the latter scenario, the fucose containing S-layer glycan from both the WT and 25 
the ∆Tffuc1 strains were compared by LC-ESI-MS with no obvious change under the growth 26 
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conditions used (Z.A. Megson, L. Neumann, F. Altmann, C. Schäffer, unpublished data). 1 
However, the microheterogeneity of the S-layer glycan regarding the terminal fucose residue 2 
complicates interpretation of MS data. Therefore, it remains unclear whether the released 3 
fucose in the periplasm can be used as a nutrient source or is recycled by the bacteria into its 4 
glycosylation pathway, and, thus, is subject of further studies. 5 
 6 
Overall, our data suggest that TfFuc1 is a unique g-L-(1,2)-fucosidase which could potentially 7 
contribute to fucose utilization in T. forsythia. In order to better elucidate this role and rule out 8 
any redundancy in the system, two further annotated fucosidases in T. forsythia, BFO_1182 9 
and BFO_3101, together with the annotated fucose permease, BFO_0307, are now being 10 
investigated to elucidate the role of fucose in the physiology of T. forsythia. 11 
 12 
Experimental Procedures 13 
 14 
Bacterial strains, medium and culture conditions. T. forsythia wild-type (WT) strain 15 
ATCC 43037 (American Type Culture Collection) and the knock-out mutant ∆Tffuc1 were 16 
grown anaerobically at 37°C for 4-7 d in brain heart infusion (BHI) broth or 0.8% (w/v) BHI 17 
agar, supplemented with N-acetylmuramic acid (NAM), horse serum and gentamycin as 18 
described previously.32 Escherichia coli DH5g and BL21 (DE3) (Invitrogen) were cultivated 19 
in selective Luria Bertani (LB) medium (agar and broth) supplemented with 100 µg/ml 20 
ampicillin (Amp). All strains and plasmids used in the course of this study are summarised in 21 
Table 3. 22 
 23 
Molecular methods. All enzymes were purchased from Fermentas. Genomic DNA of T. 24 
forsythia WT strain ATCC 43037 was isolated from 2 ml of bacterial suspension as described 25 
previously and used as the DNA template in all PCRs, unless otherwise specified.37 The 26 
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GeneJET™ Gel Extraction Kit (Fermentas) was used to purify DNA fragments from agarose 1 
gels and to purify digested plasmids and oligonucleotides. Plasmid DNA from transformed 2 
cells was isolated with the GeneJET™ Plasmid Miniprep kit (Fermentas). Agarose gel 3 
electrophoresis was performed as described elsewhere.38 Primers for PCR and DNA 4 
sequencing were purchased from Invitrogen (Table 4). PCR was performed using the 5 
Phusion®High-Fidelity DNA Polymerase (Fermentas) and a My CyclerTM (Bio-Rad) 6 
thermal cycler. Transformation of chemically competent E. coli DH5g and BL21 (DE) cells 7 
was performed according to the manufacturer’s protocol (Invitrogen). E. coli transformants 8 
were screened by PCR using RedTaq ReadyMix PCR mix (Sigma-Aldrich) and recombinant 9 
clones were analyzed by restriction mapping. Expression vector and knock-out cassette were 10 
sequenced (Microsynth) prior to transformation. 11 
 12 
Recombinant production of His6-tagged TfFuc1. The Tffuc1 gene was amplified from the 13 
chromosome of T. forsythia ATCC 43037 with a fused C-terminal His6-tag by PCR using 14 
primer pair 1/2 (Table 4). The His6-tagged amplification product was digested using 15 
restriction enzymes NdeI/XhoI and cloned into NdeI/XhoI-linearized pET22-b (Novagen). 16 
The corresponding plasmid was transformed into E. coli BL21 (DE3) cells for protein 17 
expression. Freshly transformed cells were grown in two 400-ml Erlenmeyer flasks to an 18 
OD600 of 0.4-0.5 in the presence of 100 µg/ml of Amp at which point protein expression was 19 
induced with a final concentration of 1 mM isopropyl-く-D-thiogalactopyranoside (IPTG) and 20 
cultures were shaken (200 rpm) overnight at 18°C. Cells were harvested by centrifugation 21 
(6,500 g, 20 min, 4°C). 22 
Collected bacterial cells were lysed by sonication in buffer A (50 mM phosphate 23 
buffer pH 8, 0.3 M NaCl) containing 5 mM imidazole and cleared lysates after 24 
ultracentrifugation at 150,000 g for 30 min at 4°C were incubated with 1 ml of Ni-NTA beads 25 
(Qiagen) for 1 h at 4°C, shaking slightly. The beads were placed in a chromatography column 26 
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and the His6-tagged protein was purified using an imidazole gradient in buffer A; 25 mM 1 
imidazole (10 ml), 50 mM imidazole (10 ml), followed by five elution steps with 500 µl of 2 
250 mM imidazole in buffer A. Eluted fractions containing the purified recombinant protein, 3 
rTfFuc1, as determined by SDS-PAGE analysis, were pooled and dialysed overnight at 4°C 4 
against 3 l of 10 mM phosphate buffer, pH 8.0. The volume was then reduced 5-fold using a 5 
concentration centrifuge yielding a protein concentration of 0.35 mg/ml (as determined by 6 
Nanodrop) in 50 mM phosphate buffer. 7 
 8 
Construction of a T. forsythia ∆Tffuc1 knock-out strain. Disruption of the Tffuc1 gene in 9 
T. forsythia was performed by gene knockout, as described previously.32 The Tffuc1 gene is 10 
not part of an operon, thus, downstream effects due to the chosen mutation strategy are not 11 
expected to occur. Briefly, the flanking genomic regions (1,000 bp) up-stream and down-12 
stream of Tffuc1 were amplified using primer pairs 3/4 and 5/6, respectively (Table 4). The 13 
two resulting fragments were joined with the erythromycin resistance gene ermF-ermAM 14 
(amplified using primer pair 7/8) by overlap extension PCR and sub-cloned into the blunt-end 15 
cloning vector pJET1.2 (Thermo Scientific), resulting in pJET1.2/Tffuc1_ko. Approximately 16 
5 µg of the knockout cassette was transferred by electroporation into 100 µl of competent T. 17 
forsythia cells. Cells were regenerated in BHI medium for 24 h before plating on BHI agar 18 
plates containing erythromycin (10 µg/ml) as a selection marker. Single colonies were picked 19 
and used for inoculation of liquid BHI medium. Genomic DNA of the new ∆Tffuc1 mutants 20 
were isolated as mentioned above and the absence of the Tffuc1 gene and the correct 21 
integration of the erythromycin resistance gene (upstream and downstream) was evaluated by 22 
PCR using primer pairs 1/2, 9/10, and 11/12, respectively (Table 4). Absence of the enzyme 23 
in the ∆Tffuc1 strain was also confirmed by Western immunoblotting of the total cell extract 24 
separated by SDS-PAGE using TfFuc1-specific polyclonal antiserum (Fig. 1). 25 
16 
 
General and analytical methods. SDS-PAGE was carried out according to a standard 1 
protocol using a Protean II electrophoresis apparatus (Bio-Rad).39 Protein bands were 2 
visualized with Coomassie Brilliant Blue G 250 (CBB) staining reagent. For Western 3 
immunoblotting of proteins onto a nitrocellulose membrane (Peqlab), a Mini Trans-Blot Cell 4 
(Bio-Rad) was used. Detection of the His6-tag fused to rTfFuc1 and detection of TfFuc1 was 5 
done with the Li-Cor Odyssey Infrared Imaging System using an anti-His6 mouse antibody 6 
(Roche) or TfFuc1-specific polyclonal antiserum raised in mice (EF-BIO), respectively, both 7 
in combination with goat anti-mouse IgGIR Dye 800CW conjugate (Li-Cor). 8 
 9 
Enzymatic characterization of rTfFuc1. Enzymatic characterization of rTfFuc1 was 10 
performed essentially as described elsewhere.40 0.17 µM of purified, recombinant enzyme 11 
was incubated with 5 mM of the colorimetric substrate 4-nitrophenyl-g-L-fucopyranoside 12 
(pNP-fucose) (Sigma) at a range of different pH values (3-10.25) and cation concentrations in 13 
96-well plates at 22°C in a total volume of 40 µl. The enzymatic reaction was stopped after 14 
3 min by addition of 260 µl of phosphate buffer, pH 11.4. Citrate/phosphate buffer (0.1 M) 15 
was used to assay the pH range from 3-8,41 50 mM glycine buffer was used for a pH range 16 
from 8-10. The effect of MgCl2 (5 mM, 10 mM), KCl (5 mM, 10 mM) and NaCl (50 mM, 17 
150 mM) on the enzyme’s activity was assayed in the same way in 50 mM glycine buffer, 18 
pH 9.  19 
 A 4-nitrophenol standard curve was made by measuring the absorbance at 405 nm 20 
(Abs405) of 0, 4, 8, 12, 16, 20 and 24 nmol of 4-nitrophenol per well in 300 µl of phosphate 21 
buffer, pH 11.4. The KM and Vmax catalytic constants were calculated at pH 9.0 in 22 
50 mM glycine buffer at 22°C in the presence of 0.01 to 50 mM pNP-fucose. The inhibitory 23 
effect of fucose and deoxyfuconojirimycin (DFJ) on the KM and Vmax of the enzyme were 24 
assayed in the same way in the presence of 0.25 mM fucose and 0.1 µM DFJ, respectively.28 25 
Readings were performed using an Infinite 200 plate reader (TECAN) and catalytic constants 26 
17 
 
were calculated with the Sigma Plot 12, Systat Software. 1 
 2 
Substrate specificity of rTfFuc1. For the determination of enzyme linkage specificity, a set 3 
of commercially available fucosylated substrates (2-fucosyllactose and 3-fucosyllactose from 4 
Dextra laboratories; H-Trisaccharide, Lewis A trisaccharide, Fuc-g-(1,4)-Gal and Fuc-g-(1,6)-5 
GlcNAc, all from Carbosynth) (Fig. 3) were incubated with the enzyme and reaction mixtures 6 
were analysed by HPAEC using an ICS3000 chromatographic system (Dionex, Thermo 7 
Fisher) on a CarboPac PA-1 column. Incubations were made overnight at 37°C in a total 8 
volume of 100 µl by mixing 0.34 µM of enzyme with 0.5 mM of substrate in 50 mM glycine 9 
buffer, pH 9.0. In order to minimize the effect of the buffer, the reaction volume was then 10 
diluted with 400 µl of Milli-Q water and the enzyme was removed using an Amicon 3 kDa 11 
cut-off spin column (Millipore). Twenty-five microliters of this flow through was then applied 12 
to the CarboPacPA-1 column using full-loop injection. 13 
 In order to obtain reliable activity values, the K-FUCOSE kit (Megazyme) was 14 
adapted to suit requirements. In a total volume of 250 µl of 50 mM glycine buffer at pH 9.0, 15 
the substrates 2-fucosyllactose, H-trisaccharide and Fuc-g(1,6)-GlcNAc, were incubated 16 
separately at a concentration of 0.5 mM with 1.83 µl of fucose dehydrogenase (FDH) and 17 
9.15 µl of NADP+ (both as supplied) in a cuvette at 37°C for 10 min. When the reaction had 18 
reached a constant absorbance at 340 nm (Abs340), rTfFuc1 was added to the mixture at a 19 
concentration of 0.34 µM and the formation of NADPH was followed by continuous 20 
measurement of the increase in Abs340. The activity of the enzyme on each substrate was 21 
calculated according to the supplier’s specifications from ∆Abs340/min where the formation of 22 
NADPH was linear over time. The experiment was repeated with different enzyme dilutions 23 
(1:10; 1:100) to prove the reliability of the method. 24 
The ability of the enzyme to cleave fucose residues off more complex natural glycans 25 
and those on branched sugar residues was assayed on the substrates A antigen tetraose type 5 26 
18 
 
(Carbosynth), GnGnF6-peptide, GalFGalF, and an N-glycan derived from Crassostrea 1 
virginica (Eastern oyster) haemocyte treated with chicken liver g-N-acetylgalactosaminidase 2 
and bovine く-galactosidase (both from Sigma) to reveal the underlying H epitope presenting a 3 
terminal g(1,2) fucose on an unsubstituted く(1,3)-galactose (i.e., histo blood group antigen H), 4 
referred to here as GalF42 (Fig. 3). Activity on the A antigen substrate was assayed using the 5 
K-FUCOSE kit as described above. For all other substrates, incubations were performed 6 
overnight at 37°C and analysed by MALDI-TOF MS using an Autoflex Speed instrument 7 
(Bruker) in positive ion mode with 6-aza-2-thiothymine (ATT) as matrix. Spectra were 8 
processed with the manufacturer’s software (Bruker Flexanalysis 3.3.80) using the SNAP 9 
algorithm with a signal/noise threshold of 6 for MS (unsmoothed) and then manually 10 
interpreted. 11 
 12 
rTfFuc1 activity on mucin from bovine submaxillary glands. rTfFuc1 was incubated with 13 
bovine submaxillary mucin (Sigma) in combination with the His-tagged recombinant NanH 14 
sialidase (rNanH) from T. forsythia.15 Incubations were performed at 37°C in 50 mM glycine 15 
buffer, pH 9.0, at a final concentration of 0.1 µM of either enzyme, 0.2 mg/ml of mucin and 16 
NADP+ and FDH as described above, in a total volume of 250 µl. rTfFuc1 (and rNanH) was 17 
added to the mixture after an initial 5-min incubation period. The release of fucose (∆Abs340) 18 
was followed over 10 min and calculated according to the supplier’s specifications from 19 
∆Abs340/min where the formation of NADPH was linear over time. 20 
 21 
Presence of TfFuc1 in T. forsythia membrane, outer membrane and non-membrane 22 
preparations. Cells were harvested by centrifugation from a 4-day-old 100-ml T. forsythia 23 
culture. Separation of cellular fractions was performed as described previously.24 Briefly, 24 
cells were washed once in Tris (2-amino-2-hydroxymethyl-propane-1,3-diol)-buffer, pH 7.5, 25 
sonicated, and cell debris were removed by centrifugation. The collected supernatant was 26 
19 
 
ultracentrifuged (100,000 g, 4°C, 40 min) to separate the whole membrane fraction (pellet) 1 
from the membrane non-associated fraction (cytoplasm and periplasm, supernatant). The 2 
pellet was resuspended in 2% (w/v) N-lauroylsarcosine (Sigma) in Tris buffer and mixed. 3 
After incubation (2 h, 25°C), the outer membrane fraction (OM) was collected by 4 
centrifugation (100,000 g, 4°C, 40 min) and the pellet was resuspended in Tris buffer. The 5 
protein content was determined in each fraction by the Bradford method (Bio-Rad).43 A total 6 
of 20 µg of protein from the OM and non-membrane associated fractions and 400 µg of the 7 
membrane fraction was loaded onto an SDS-PAGE gel and ran as described above. The 8 
presence of TfFuc1 in each fraction was determined by Western immunoblotting. 9 
 10 
Microtiter assays of Hoechst-stained biofilms. T. forsythia WT and 〉Tffuc1 strains were 11 
compared in respect to the biofilm formation44 on mucin-coated polystyrene microtiter plates 12 
in dependency of the strength of the BHI liquid medium. Biofilm was stained with Hoechst 13 
33258 Fluorescent Stain (Thermo Scientific). Details are described in the Supplementary 14 
Information. 15 
 16 
Attachment and invasion assays. For both attachment and invasion assays, T. forsythia WT 17 
and 〉Tffuc1 strains were incubated with the oral epithelial cell line H357 (CCL17; American 18 
Type Culture Collection) at a multiplicity of infection of 1:100, as described previously.45 19 
Details are described in the Supplementary Information 20 
 21 
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Figure legends 1 
 2 
Figure 1. SDS PAGE (A.) and Western immunoblot (B.) of total cell extracts from T. 3 
forsythia WT (lane 2) and ∆Tffuc1 strains (lane 3) and of the His6-tagged rTfFuc1 as purified 4 
from E. coli (lane 4), used for activity studies and to raise a polyclonal anti-TfFuc1 antiserum. 5 
Western immunoblotting using the anti-TfFuc1 antiserum recognized the protein (~51 kDa) 6 
specifically in the WT strain (lane 2) and indicated absence of the protein in the ∆Tffuc1 strain 7 
(lane 3), proving that the enzyme was effectively knocked-out. In the preparation of rTfFuc 1 8 
(B., lane 4), the polyclonal antiserum recognizes also minor contaminating E. coli proteins not 9 
visible on the SDS-PAGE gel (A., lane 4). Mm; PageRuler Plus prestained protein ladder 10 
(Thermo Scientific). 11 
 12 
Figure 2. pH profile of rTfFuc1 using 4-nitrophenyl-α-L-fucopyranoside (pNP-fucose) as a 13 
substrate. Activity was measured as the increase in Abs405 due to the released 4-nitrophenol 14 
product. Citrate/phosphate buffer (0.1 M) was used to assay the pH range from 3-8, 50 mM 15 
glycine buffer was used for the pH range from 8-10.25. 16 
 17 
Figure 3. Fucosylated substrates used in this study. The structures are depicted according to 18 
the symbolic nomenclature of the Consortium for Functional Glycomics 19 
(http://www.functionalglycomics.org/static/consortium/Nomenclature.shtml). 20 
 21 
Figure 4. rTfFuc1 activity on standard fucosylated substrates after overnight incubation as 22 
determined by HPAEC. Blue lines represent samples which were incubated in absence of 23 
rTfFuc1 (substrate standard) and red lines represent samples incubated in the presence of 24 
rTfFuc1. Cleavage of the substrates was determined by the appearance of a fucose peak, as 25 
determined by the retention time of the standard monosaccharide. 26 
27 
 
Figure 5. Cleavage of natural g(1,2) fucosylated glycans by rTfFuc1. Cleavage of fucose 1 
from a large N-glycan substrate was monitored by MALDI-TOF MS spectra after overnight 2 
incubation; the conversion of the m/z 1703 glycan (GalF) to one of m/z 1557 (∆m/z 146) is 3 
indicative of the loss of fucose. The structures of the substrate and product are depicted 4 
according to the symbolic nomenclature of the Consortium for Functional Glycomics. 5 
 6 
Figure 6. rTfFuc1 was incubated with mucin from bovine submaxillary glands and the release 7 
of fucose was measured with the K-FUCOSE kit. When incubations were performed in 8 
conjunction with the rNanH sialidase, a slow steady increase in the Abs340 was observed. The 9 
activity was calculated over a period of 300 s where the data points fitted a linear regression 10 
with an r2 of 0.98. No activity could be detected, when rTfFuc1 was incubated alone with the 11 
mucin. The ∆Abs340 lead to an irregular data set with a very low r2 value of 0.4. 12 
 13 
Figure 7. Presence of TfFuc1 in cell fractions of T. forsythia WT. A. SDS-PAGE analysis of 14 
the outer membrane fraction (OM) (1), membrane fraction (2) and non-membrane associated 15 
fraction (3) showed good separation between the fractions, as the S-layer bands were very 16 
prominent in the OM but not in the membrane and non-membrane associated fractions. 17 
Protein loaded was 20 µg of the OM and non-membrane associated fractions and 400 µg of 18 
the membrane fraction. Protein visualization was by CBB. B. Western immunoblot using anti-19 
TfFuc1 antiserum showed the TfFuc1 fucosidase in the non-membrane associated fraction 20 
comprising both the cytoplasmic and periplasmic content. Mm; PageRuler Plus prestained 21 
protein ladder (Thermo Scientific). 22 
  23 
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Table 1. rfFuc1 activity on 4-nitrophenyl-g-L-fucopyranoside (pNP-fucose). Catalytic 1 
constants KM and Vmax and the inhibitory effect of DFJ and L-fucose were measured using the 2 
colorimetric substrate pNP-fucose within a concentration range from 0.01 to 50 mM at 22°C 3 
in glycine buffer at pH 9.0 4 
 5 
Substrate* Inhibitor KM (mM) Vmax (U/mg)** 
pNp-fucose None 0.67 (±0.2) 20.4 (±0.8) 
pNp-fucose 0.1 µM DFJ*** 28.3 (±3.7) 28.1 (±2.4) 
pNp-fucose 0.25 mM Fucose 16.5 (±4.7) 28.6 (±4.4) 
 6 
*4-nitrophenyl-g-L-fucopyranoside 7 






Table 2. rTfFuc1 activity on standard fucosylated substrates. Cleavage was determined by HPAEC after overnight incubations with rTfFuc1 (see 












*µmol/min/mg of enzyme 
  






2-Fucosyllactose g-L-Fuc-1,2-く-D-Gal-1,4-D-Glc g(1,2) Yes 0.8 
3-Fucosyllactose く-D-Gal-1,4(g-L-Fuc-1,3)-D-Glc g(1,3) No - 
H-trisaccharide g-L-Fuc-1,2-く-D-Gal-1,3-く-D-GlcNAc g(1,2) Yes 0.6 
Lewis A trisaccharide く-D-Gal-1,3(g-L-Fuc-1,4)-く-D-GlcNAc g(1,4) No - 
Fuc(1,6)GlcNAc g-L-Fuc-1,6-く-D-GlcNAc g(1,6) Yes 0.35 
Fuc(1,4)Gal g-L-Fuc-1,4-く-D-Gal g(1,4) No - 
A antigen tetraose く-GalNAc-1,3(g-L-Fuc-1,2)-く-D-Gal-1,4-D-Glc g(1,2) No - 
30 
 
Table 3. Bacterial strains and plasmids used in this study 
Strain or plasmid Genotype and/or relevant characteristic(s) Source 
Escherichia coli DH5g 
F- 80dlacZ M15 (lacZYA-argF)U169 deoR recA1 endA1 
hsdR17 (rK-mK-) phoA supE44 thi-1 gyrA96 relA1- 
Invitrogen 
Escherichia coli BL21 (DE) F-, ompT, hsdS (rB-mB-), gal, dcm (DE3) Invitrogen 
Tannerella forsythia ATCC 43037 Wild-type isolate American Type Culture Collection, USA 
T. forsythia ∆Tffuc1 T. forsythia knockout of the Tffuc1 gene; Ermr This study 
pET-22b (+) Expression vector with a His6-tag, Ampr Novagen 





Table 4. Oligonucleotide primers used for PCR amplification reactionsa 














a. Artificial restriction sites are underlined. Lowercase letters indicate artificially introduced bases to improve restriction enzyme cutting. 
In italics are the overlap sequences complementary to ermF-ermAM. In bold are the overlap sequences complementary to the BFO_2737 flanking 
regions. 
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The periodontal pathogen Tannerella forsythia expresses several glycosidases which are 3 
linked to specific growth requirements and are involved in the invasion of host tissues. g-L-4 
fucosyl residues are exposed on various host glycoconjugates and, thus, the g-L-fucosidases 5 
predicted in the T. forsythia ATCC 43037 genome could potentially serve roles in host-6 
pathogen interactions. We describe the molecular cloning and characterization of the putative 7 
fucosidase TfFuc1 (encoded by the bfo_2737 = Tffuc1 gene), previously reported to be 8 
present in an outer membrane preparation. In terms of sequence, this 51-kDa protein is a 9 
member of the glycosyl hydrolase family GH29. Using an artificial substrate, p-nitrophenyl-10 
g-fucose (KM 670 µM), the enzyme was determined to have a pH optimum of 9.0 and to be 11 
competitively inhibited by fucose and deoxyfuconojirimycin. TfFuc1 was shown here to be a 12 
unique g(1,2)-fucosidase that also possesses g(1,6) specificity on small unbranched substrates. 13 
It is active on mucin after sialidase-catalysed removal of terminal sialic acid residues and also 14 
removes fucose from blood group H. Following knock-out of the Tffuc1 gene and analysing 15 
biofilm formation and cell invasion/adhesion of the mutant in comparison to the wild-type, it 16 
is most likely that the enzyme does not act extracellularly. Biochemically interesting as the 17 
first fucosidase in T. forsythia to be characterized, the biological role of TfFuc1 may well be 18 
in the metabolism of short oligosaccharides in the periplasm, thereby indirectly contributing 19 
to the virulence of this organism. TfFuc1 is the first glycosyl hydrolase in the GH29 family 20 
reported to be a specific g(1,2)-fucosidase. 21 





Tannerella forsythia is a Gram-negative anaerobic oral pathogen, a member of the so-called 3 
“red complex” of bacteria that cause a set of inflammatory diseases named periodontitis, 4 
affecting millions of people worldwide.1-3 The effects on the periodontium include loss of the 5 
alveolar bone around the teeth, swelling and bleeding of the gum and, in more severe cases, 6 
loss of teeth. Periodontitis has also been linked to systemic inflammation and to an increased 7 
risk of stroke, heart attacks and atherosclerosis, amongst others.4 8 
 Like other bacteria residing in human hosts, T. forsythia has adapted to better suit its 9 
niche with cell surface glycosylation thought to be key to this adaptation.5 As previously 10 
described, T. forsythia cells are completely covered by a unique surface (S-) layer formed by 11 
co-assembly of two different proteins both of which are highly O-glycosylated with an 12 
equally unique glycan.6-8 Mutant strains lacking either the S-layer or glycan assembly and 13 
maturation genes, display phenotypes involving altered human cell attachment to host cells, 14 
biofilm formation, and disease progression.9-11 In addition, the structure of the glycan partially 15 
imitates that of host glycoproteins, having a terminal sialic acid-like residue (precisely, a 16 
modified pseudaminic acid residue) and a terminal fucose, with the latter shown to be present 17 
in substoichiometric amounts and linked to a methylated galactose in an unknown glycosidic 18 
linkage.8 The glycobiology of this pathogen, including its repertoire of glycosidases, seems to 19 
be key to its physiology and, potentially, its pathogenicity.5, 12  20 
Recent evidence suggests that for several periodontal pathogens, but particularly for 21 
the “red complex” organism T. forsythia, sialic acid-containing host molecules play an 22 
important role in vivo.13 Two different sialidases have been found in T. forsythia, SiaHI and 23 
NanH. In the case of SiaHI, its function is unclear. It is not a canonical sialidase (i.e., not in 24 
the GH35 family), a siaH1 mutant has no discernible phenotype, and experiments point to it 25 
being a periplasmic protein without any role in extracellular interactions.14 These same studies 26 
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also indicated that mutants lacking the main T. forsythia sialidase NanH had hindered 1 
attachment and invasion of human oral epithelial cells. The enzyme was also seen to play an 2 
important role in biofilm growth on surfaces coated with salivary glycoproteins.15 The nanH 3 
gene is located in a large cluster that contains all the genes required for sialic acid catabolism, 4 
which indicates that the cleaved sialic acid can additionally be taken up and utilized.12, 13 This 5 
gene cluster also contains a く-hexosaminidase that may cleave sub-terminal residues after 6 
sialidase action and may also play a role in vivo.15 Additionally, in a separate study, 7 
transcriptome analysis of the oral microbiome also showed up-regulation of the sialidase 8 
nanH mRNA in dental plaque.16 9 
g-L-fucosyl residues are, like sialic acid, frequently located at a terminal position on 10 
various host glycoconjugates including blood groups, milk oligosaccharides, gastric and 11 
submaxillary mucin, and serum glycoproteins.17, 18 Therefore, fucosidases in T. forsythia 12 
could potentially play similar roles to sialidases.19 It has generally been shown that terminal 13 
fucose residues play important roles in mammalian cell-cell communication and also in their 14 
interaction with pathogenic bacteria; for instance, Campylobacter jejuni and Helicobacter 15 
pylori are known to bind certain fucosylated blood groups (e.g., O-antigen) in order to 16 
mediate infection.19-21 In addition, the ability to utilize available fucose provides many 17 
bacteria with a nutritional advantage and contributes to survival in a highly competitive 18 
ecosystem, such as the human body.22, 23 19 
Characterization of g-L-fucosidases in T. forsythia could aid in the elucidation of the 20 
structure-function relationship of fucosylated host and bacterial surfaces in the virulence of 21 
oral pathogens. The genome of T. forsythia encodes three putative g-L-fucosidases, 22 
BFO_2737 and BFO_1182, both classified in the CAZy (Carbohydrate Active enZymes; 23 
http://www.cazy.org/) glycosyl hydrolase family GH29, and BFO_3101, classified in family 24 
GH95. While all three enzymes possess a glycosyl hydrolase domain and are classified by 25 
CAZy according to their mechanism of action, BFO_1182 and BFO_3101 are not strictly 26 
6 
 
annotated as g-L-fucosidases but as a F5/8 type C domain protein and a putative lipoprotein, 1 
respectively. 2 
Here, we describe the molecular cloning and characterization of BFO_2737, which we 3 
named TfFuc1. This protein has previously been reported to form part of an outer membrane 4 
preparation of T. forsythia 24 and, thus, was a good candidate to be involved in host-pathogen 5 
interactions. TfFuc1 is a 446-amino acid protein with a theoretical pI and molecular mass of 6 
6.9 and 50.8 kDa, respectively. It is the first fucosidase in this organism to be characterized to 7 
date. The enzyme was shown here to be an g(1,2)-fucosidase and also possesses an g(1,6) 8 
specificity on small unbranched substrates. It is a predicted periplasmic protein, possibly 9 
playing a role in the breakdown of small oligosaccharides. It is, to the best of our knowledge, 10 




Enzymatic characterization of rTfFuc1. The Tffuc1 gene was cloned into pET22-b(+) 15 
vector and expressed in E. coli as a C-terminally His6-tagged protein, which enabled 16 
purification via nickel affinity chromatography (Fig. 1). The enzymatic activity was then 17 
tested using the standard colorimetric g-fucosidase substrate 4-nitrophenyl-g-L-18 
fucopyranoside (pNP-fucose) at 22°C in a range of different pH values and in the presence of 19 
MgCl2, KCl and NaCl, in order to establish its pH optimum and cation dependence, 20 
respectively. By stopping the reaction with the addition of an alkaline buffer at pH 11.4, it 21 
was ensured that all wells where at the same pH for consequent absorbance readings. The 22 
activity of the enzyme was seen to start to plateau at the neutral to alkaline pH range and was 23 
considered most active at pH 9.0, assayed in glycine buffer, and not at pH 9.25 where the 24 
activity suddenly peaks and then rapidly decreases thereafter. The activity remained largely 25 
unaffected by the presence of cations at the two concentrations tested (results not shown). The 26 
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KM and Vmax catalytic constants at 22°C, calculated from the activity of the enzyme at 1 
different pNP-fucose concentrations, were 670 µM and 20.4 µmol/min (U) per mg of protein, 2 
respectively (Table 1). The determined catalytic constants for rTffuc1 are in the range of 3 
those reported for other fucosidases/ glycosylhydrolases when tested on their corresponding 4 
pNP-substrates.25-27 5 
 6 
Substrate linkage specificity of rTfFuc1. To determine the enzyme linkage specificity, 7 
rTfFuc1 was incubated with a set of different fucosylated substrates of defined structure 8 
representing a range of fucose linkages available on host glycoproteins and on oral surfaces 9 
(Fig. 3). The reaction products obtained after overnight incubation were analysed using high-10 
pH anion-exchange chromatography with pulsed amperometric detection (HPAEC) where the 11 
release of fucose was confirmed by comparison with the retention time of the standard 12 
monosaccharide and of a substrate standard after overnight incubation at 37°C. The enzyme 13 
was seen to be active on both g(1,2) fucose containing substrates, 2-fucosyllactose and H-14 
trisaccharide, and on the g(1,6) fucose disaccharide g-L-Fuc-(1,6)-く-D-GlcNAc, although this 15 
latter reaction did not reach completion, indicating weak specificity for this linkage. The 16 
g(1,3) and g(1,4) linkages were not cleaved on 3-fucosyllactose and the Lewis A 17 
trisaccharide, respectively. The enzyme was also inactive on the substrate g-L-Fuc-(1,4)-く-D-18 
Gal, added as a second disaccharide control to prove that the g(1,6) activity was not due to 19 
differences in substrate length (Fig. 4). 20 
 In order to obtain accurate activity values on the cleaved substrates, the K-FUCOSE 21 
kit from Megazyme was used, coupled to the enzymatic reaction with rTfFuc1. First, FDH, 22 
which also has an alkaline pH optimum, and NADP+ were added to the substrate solution 23 
reaction mixture in order to convert any free fucose already present in the sample to L-fucono-24 
1,5-lactone by the reduction of NADP+ to NADPH (ε340 = 6.022 mM-1cm-1). rTfFuc1 was then 25 
added to the mixture and the reaction was monitored by following the increase in Abs340. The 26 
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activity was calculated from where the formation of NADPH was linear over time. The 1 
enzyme was most active on 2-fucosyllactose and H-trisaccharide with specific activities of 2 
0.8 U/mg and 0.6 U/mg, respectively. The activity on the g(1,6) disaccharide was 3 
significantly lower at 0.35 U/mg (Table 2). 4 
 The activity of the enzyme on the various substrates could be calculated 5 
approximately (as some loss of material occurred during sample preparation) from the HPLC 6 
experiments after 1-h incubation periods (results not shown) and was found to be markedly 7 
lower than that observed with the K-FUCOSE kit, indicating that free fucose, which is 8 
consumed in the latter, could be inhibiting the enzymatic activity significantly. In order to 9 
determine the extent of such an effect, measurement of KM and Vmax values were repeated 10 
with pNP-fucose in the presence of either 0.25 mM L-fucose or 0.1 µM deoxyfuconojirimycin 11 
(DFJ), which is a strong fucosidase inhibitor.28 The enzyme was competitively inhibited by 12 
both fucose and DFJ as the Vmax remained largely unaffected but the KM value increased from 13 
0.67 mM to 16.5 mM and 28.3 mM, respectively (Table 1). 14 
 Further, the ability of the enzyme to cleave fucose residues off more complex 15 
natural glycans and those on branched sugar residues was assayed (compare with Fig. 3). As 16 
expected, the enzyme was unable to cleave the g(1,3) fucose linkage on GalFGalF-pep, 17 
included in the assays as a trace amount of activity could be observed when using 3-18 
fucosyllactose, as measured by the K-FUCOSE kit. The enzyme was also not able to cleave 19 
the core g-1,6 fucose linkage on GnGnF6-pep nor the branched g(1,2)-linked fucose on the 20 
A antigen. The non-branched g(1,2) fucose linkage present on the Eastern oyster substrate, 21 
however, was cleaved off the substrate GalF, seen by the loss of a fucose residue in the MS 22 
spectra of the substrate. The major m/z 1703 glycan ([M+H]+) was approximately 50% 23 
digested to a defucosylated species of m/z 1557 after overnight incubation with the enzyme 24 
(Fig. 5). The enzyme is, therefore, able to cleave off fucose residues which are g(1,2) linked 25 
on more complex glycans only when in a terminal unbranched position and is unable to cleave 26 
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core g(1,6) fucose. This data supports that the enzyme acts as an g(1,2) fucosidase. 1 
 2 
rTfFuc1 activity on bovine submaxillary mucin. rTfFuc1 was incubated with mucin from 3 
bovine submaxillary glands and the release of fucose was measured with the K-FUCOSE kit. 4 
Incubation was performed also in combination with rNanH from T. forsythia and activities 5 
were calculated from the slope of 〉Abs340 where it was linear over time. During the assayed 6 
incubation period of 10 min, no activity could be detected when rTfFuc1 was incubated alone 7 
with mucin. The 〉Abs340 lead to an irregular data set with a very low r2 value. However, 8 
fucose release was detectable when the incubation was performed in conjunction with the 9 
rNanH sialidase, presenting a slow but steady increase in the Abs340. The activity was 10 
calculated over a period of 300 s where the data points fitted a linear regression with an r2 of 11 
0.98 (Fig. 6). The experiment was repeated several times and yielded an activity of 24 12 
±4 mU/mg. rTfFuc1 might cleave fucose off mucin over longer periods of time, but the data 13 
shows a significantly higher activity when sialic acid residues are first removed from mucin, 14 
indicating that the fucosidase TfFuc1 could work downstream from the sialidase in T. 15 
forsythia and presumably cooperate with other glycosidases in the degradation of complex 16 
glycans. 17 
 18 
Cellular localization of TfFuc1. TfFuc1 was previously reported to be present in the outer 19 
membrane fraction of T. forsythia.24 In an effort to investigate its presence on the surface of T. 20 
forsythia cells, TfFuc1-specific polyclonal antiserum was raised against the recombinant 21 
enzyme in mice and used for Western immunoblotting of cellular fractions separated by SDS-22 
PAGE. Protein visualization by CBB staining showed good separation between the fractions, 23 
as the S-layer bands were very prominent in the outer membrane fraction but not in the inner-24 
membrane and non-membrane associated fractions. Western immunoblotting showed that all 25 
the detectable TfFuc1 fucosidase was found in the non-membrane associated fraction 26 
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comprising both the cytoplasmic and periplasmic content (Fig. 7), arguing against surface 1 




Colonization of the periodontal pocket by the pathogenic late colonizer T. forsythia depends 6 
largely on pre-existing bacteria that have already tipped the oral balance away from health 7 
and towards disease.29 Factors such as a pH shift from neutral to alkaline and slight raises in 8 
the temperature due to the host inflammatory response could be contributing factors favouring 9 
the process.30 In a situation of oral disease, the number of different bacteria living in the 10 
gingival crevice decreases markedly due to putative pathogenic bacteria being more 11 
competitive in such an environment.31 It is in these conditions that T. forsythia seems to thrive 12 
and becomes one of the key players in severe cases of periodontitis. 13 
 The NanH sialidase in T. forsythia has been well established to play important roles 14 
in adherence to sialylated glycoprotein-coated surfaces and epithelial cells in addition to 15 
triggering biofilm growth and being up-regulated in dental plaque.14-16 As the other important 16 
terminal sugar on host glycoproteins is fucose, here, we performed an initial characterization 17 
of a putative g-L-fucosidase encoded in the T. forsythia genome, product of the gene Tffuc1, 18 
previously reported to be part of the outer membrane proteome.24 19 
 By producing the enzyme recombinantly in E. coli we were able to show that the 20 
enzyme is active across a broad pH range from 7.0-9.0, having an unusually high pH optimum 21 
of 9.0. It presents a unique g(1,2)-linkage specificity on terminal non-branched fucose 22 
residues, being also active on small non-branched g(1,6) fucosylated substrates. Whilst both 23 
these linkages are cleaved at a considerable rate in the case of small linear substrates, the 24 
g(1,6) specificity is not detected on core fucoses on more complex glycopeptides. The g(1,2) 25 
linkage specificity was apparent on both small linear substrates, such as 2-fucosyllactose and 26 
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H-trisaccharide, and on more complex glycans only when fucose occupied a terminal 1 
position, but not on a branched substrate where the fucose residue is linked to a fully 2 
substituted sugar. The enzyme seems to be, to the best of our knowledge, the first fucosidase 3 
in its GH family (GH29) to have a specific g(1,2) activity. The broad, high pH activity profile 4 
of this fucosidase ties in with its physiological niche which is known to have a pH that rises as 5 
periodontal disease progresses.30 The possession of such enzymes with higher activities in 6 
alkaline surroundings could contribute to competiveness and virulence of T. forsythia in a 7 
diseased environment.  8 
 During the course of this study, it became clear that one of the issues possibly 9 
underlining our observations was the enzyme’s cellular localization. Even though TfFuc1 was 10 
found previously to be present in the outer membrane proteome of the pathogen,24 localization 11 
of the enzyme on the surface of T. forsythia cells by fluorescent immunolabelling was not 12 
successful (data not shown; see Experimental Procedures in the Supplementary Information) 13 
and cell fractionation also showed the detectable protein to be found in the non-membrane 14 
associated fraction (Fig. 7). This would be in agreement with bioinformatics interrogation 15 
indicating that, while it has a Sec-dependent secretion signal (as predicted by SignalP 4.1 16 
Server), it is not predicted to reside in the outer membrane or be secreted, nor does it contain a 17 
T9SS C-terminal secretion signal.32 The difference in location of TfFuc1 between the present 18 
study and the outer membrane proteomics experiment24 can be reconciled when considering 19 
that in the latter study, cross-contamination of individual proteins between cellular fractions 20 
was not investigated. 21 
 Incubation of the recombinant fucosidase with bovine submaxillary mucin showed 22 
no detectable release of fucose over an incubation period of 10 min. Activity on this complex 23 
substrate could only be detected when the incubation was performed in combination with the 24 
recombinant NanH sialidase from T. forsythia. It is, therefore, conceivable that TfFuc1 could 25 
play an accompanying role to the sialidase in the interaction between T. forsythia and host 26 
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glycoproteins, but given its periplasmic location, this could merely reflect the need for 1 
removal of terminal sialic acid residues for the enzyme to work, either indicating that it most 2 
likely acts on internalised fucosyl substrates after sialic acid has already been removed by the 3 
action of sialidases or, less likely, that it acts in concert with sialidases externally. 4 
 This notion that the T. forsythia fucosidase TfFuc1 plays an internal role was 5 
corroborated when we tested the effect of the ∆Tffuc1 mutation on the ability of T. forsythia to 6 
interact with and invade human oral epithelial cells using an antibiotic protection assay on the 7 
oral epithelial cell line H357.33 We found no significant differences in the ability of the 8 
∆Tffuc1 to invade these human cells as compared to the WT strain (Fig. S1), indicating that 9 
TfFuc1 has no effect on epithelial cell-invasion under the conditions tested. In addition, the 10 
mutant did not show hindered biofilm formation when cultured on bovine submaxillary 11 
mucin, contrary to the T. forsythia NanH sialidase mutant,15 but showed a slightly increased 12 
biofilm formation (Fig. S2). 13 
 Our data supports the idea of a periplasmic fucosidase involved in the final 14 
breakdown of small substrates that have been internalized, possibly owing to the action of 15 
exoglycosidases and endoglycosidases which break-down larger glycans on the outside of the 16 
cell.34, 35 TfFuc1 would possibly then be able to exert its full potential freeing both g(1,2) and 17 
g(1,6) fucoses on small linear substrates. These findings are also in agreement with the 18 
hypothesis that the fucosidase acts downstream of the sialidases, which have been shown to 19 
act on whole glycoproteins on bacterial and host surfaces.14, 15, 36 The sialic acid would, 20 
therefore, already be missing as smaller parts of the glycan are transported inside the cell. 21 
 T. forsythia has no straightforwardly identifiable fucose catabolism locus in its 22 
genome, nor does it have the bifunctional L-fucokinase/GDP-fucose pyrophosphorylase 23 
required normally for Bacteroidetes to recycle the fucose into its glycans.23 In an effort to see 24 
the effect on the latter scenario, the fucose containing S-layer glycan from both the WT and 25 
the ∆Tffuc1 strains were compared by LC-ESI-MS with no obvious change under the growth 26 
13 
 
conditions used (Z.A. Megson, L. Neumann, F. Altmann, C. Schäffer, unpublished data). 1 
However, the microheterogeneity of the S-layer glycan regarding the terminal fucose residue 2 
complicates interpretation of MS data. Therefore, it remains unclear whether the released 3 
fucose in the periplasm can be used as a nutrient source or is recycled by the bacteria into its 4 
glycosylation pathway, and, thus, is subject of further studies. 5 
 6 
Overall, our data suggest that TfFuc1 is a unique g-L-(1,2)-fucosidase which could potentially 7 
contribute to fucose utilization in T. forsythia. In order to better elucidate this role and rule out 8 
any redundancy in the system, two further annotated fucosidases in T. forsythia, BFO_1182 9 
and BFO_3101, together with the annotated fucose permease, BFO_0307, are now being 10 
investigated to elucidate the role of fucose in the physiology of T. forsythia. 11 
 12 
Experimental Procedures 13 
 14 
Bacterial strains, medium and culture conditions. T. forsythia wild-type (WT) strain 15 
ATCC 43037 (American Type Culture Collection) and the knock-out mutant ∆Tffuc1 were 16 
grown anaerobically at 37°C for 4-7 d in brain heart infusion (BHI) broth or 0.8% (w/v) BHI 17 
agar, supplemented with N-acetylmuramic acid (NAM), horse serum and gentamycin as 18 
described previously.32 Escherichia coli DH5g and BL21 (DE3) (Invitrogen) were cultivated 19 
in selective Luria Bertani (LB) medium (agar and broth) supplemented with 100 µg/ml 20 
ampicillin (Amp). All strains and plasmids used in the course of this study are summarised in 21 
Table 3. 22 
 23 
Molecular methods. All enzymes were purchased from Fermentas. Genomic DNA of T. 24 
forsythia WT strain ATCC 43037 was isolated from 2 ml of bacterial suspension as described 25 
previously and used as the DNA template in all PCRs, unless otherwise specified.37 The 26 
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GeneJET™ Gel Extraction Kit (Fermentas) was used to purify DNA fragments from agarose 1 
gels and to purify digested plasmids and oligonucleotides. Plasmid DNA from transformed 2 
cells was isolated with the GeneJET™ Plasmid Miniprep kit (Fermentas). Agarose gel 3 
electrophoresis was performed as described elsewhere.38 Primers for PCR and DNA 4 
sequencing were purchased from Invitrogen (Table 4). PCR was performed using the 5 
Phusion®High-Fidelity DNA Polymerase (Fermentas) and a My CyclerTM (Bio-Rad) 6 
thermal cycler. Transformation of chemically competent E. coli DH5g and BL21 (DE) cells 7 
was performed according to the manufacturer’s protocol (Invitrogen). E. coli transformants 8 
were screened by PCR using RedTaq ReadyMix PCR mix (Sigma-Aldrich) and recombinant 9 
clones were analyzed by restriction mapping. Expression vector and knock-out cassette were 10 
sequenced (Microsynth) prior to transformation. 11 
 12 
Recombinant production of His6-tagged TfFuc1. The Tffuc1 gene was amplified from the 13 
chromosome of T. forsythia ATCC 43037 with a fused C-terminal His6-tag by PCR using 14 
primer pair 1/2 (Table 4). The His6-tagged amplification product was digested using 15 
restriction enzymes NdeI/XhoI and cloned into NdeI/XhoI-linearized pET22-b (Novagen). 16 
The corresponding plasmid was transformed into E. coli BL21 (DE3) cells for protein 17 
expression. Freshly transformed cells were grown in two 400-ml Erlenmeyer flasks to an 18 
OD600 of 0.4-0.5 in the presence of 100 µg/ml of Amp at which point protein expression was 19 
induced with a final concentration of 1 mM isopropyl-く-D-thiogalactopyranoside (IPTG) and 20 
cultures were shaken (200 rpm) overnight at 18°C. Cells were harvested by centrifugation 21 
(6,500 g, 20 min, 4°C). 22 
Collected bacterial cells were lysed by sonication in buffer A (50 mM phosphate 23 
buffer pH 8, 0.3 M NaCl) containing 5 mM imidazole and cleared lysates after 24 
ultracentrifugation at 150,000 g for 30 min at 4°C were incubated with 1 ml of Ni-NTA beads 25 
(Qiagen) for 1 h at 4°C, shaking slightly. The beads were placed in a chromatography column 26 
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and the His6-tagged protein was purified using an imidazole gradient in buffer A; 25 mM 1 
imidazole (10 ml), 50 mM imidazole (10 ml), followed by five elution steps with 500 µl of 2 
250 mM imidazole in buffer A. Eluted fractions containing the purified recombinant protein, 3 
rTfFuc1, as determined by SDS-PAGE analysis, were pooled and dialysed overnight at 4°C 4 
against 3 l of 10 mM phosphate buffer, pH 8.0. The volume was then reduced 5-fold using a 5 
concentration centrifuge yielding a protein concentration of 0.35 mg/ml (as determined by 6 
Nanodrop) in 50 mM phosphate buffer. 7 
 8 
Construction of a T. forsythia ∆Tffuc1 knock-out strain. Disruption of the Tffuc1 gene in 9 
T. forsythia was performed by gene knockout, as described previously.32 The Tffuc1 gene is 10 
not part of an operon, thus, downstream effects due to the chosen mutation strategy are not 11 
expected to occur. Briefly, the flanking genomic regions (1,000 bp) up-stream and down-12 
stream of Tffuc1 were amplified using primer pairs 3/4 and 5/6, respectively (Table 4). The 13 
two resulting fragments were joined with the erythromycin resistance gene ermF-ermAM 14 
(amplified using primer pair 7/8) by overlap extension PCR and sub-cloned into the blunt-end 15 
cloning vector pJET1.2 (Thermo Scientific), resulting in pJET1.2/Tffuc1_ko. Approximately 16 
5 µg of the knockout cassette was transferred by electroporation into 100 µl of competent T. 17 
forsythia cells. Cells were regenerated in BHI medium for 24 h before plating on BHI agar 18 
plates containing erythromycin (10 µg/ml) as a selection marker. Single colonies were picked 19 
and used for inoculation of liquid BHI medium. Genomic DNA of the new ∆Tffuc1 mutants 20 
were isolated as mentioned above and the absence of the Tffuc1 gene and the correct 21 
integration of the erythromycin resistance gene (upstream and downstream) was evaluated by 22 
PCR using primer pairs 1/2, 9/10, and 11/12, respectively (Table 4). Absence of the enzyme 23 
in the ∆Tffuc1 strain was also confirmed by Western immunoblotting of the total cell extract 24 
separated by SDS-PAGE using TfFuc1-specific polyclonal antiserum (Fig. 1). 25 
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General and analytical methods. SDS-PAGE was carried out according to a standard 1 
protocol using a Protean II electrophoresis apparatus (Bio-Rad).39 Protein bands were 2 
visualized with Coomassie Brilliant Blue G 250 (CBB) staining reagent. For Western 3 
immunoblotting of proteins onto a nitrocellulose membrane (Peqlab), a Mini Trans-Blot Cell 4 
(Bio-Rad) was used. Detection of the His6-tag fused to rTfFuc1 and detection of TfFuc1 was 5 
done with the Li-Cor Odyssey Infrared Imaging System using an anti-His6 mouse antibody 6 
(Roche) or TfFuc1-specific polyclonal antiserum raised in mice (EF-BIO), respectively, both 7 
in combination with goat anti-mouse IgGIR Dye 800CW conjugate (Li-Cor). 8 
 9 
Enzymatic characterization of rTfFuc1. Enzymatic characterization of rTfFuc1 was 10 
performed essentially as described elsewhere.40 0.17 µM of purified, recombinant enzyme 11 
was incubated with 5 mM of the colorimetric substrate 4-nitrophenyl-g-L-fucopyranoside 12 
(pNP-fucose) (Sigma) at a range of different pH values (3-10.25) and cation concentrations in 13 
96-well plates at 22°C in a total volume of 40 µl. The enzymatic reaction was stopped after 14 
3 min by addition of 260 µl of phosphate buffer, pH 11.4. Citrate/phosphate buffer (0.1 M) 15 
was used to assay the pH range from 3-8,41 50 mM glycine buffer was used for a pH range 16 
from 8-10. The effect of MgCl2 (5 mM, 10 mM), KCl (5 mM, 10 mM) and NaCl (50 mM, 17 
150 mM) on the enzyme’s activity was assayed in the same way in 50 mM glycine buffer, 18 
pH 9.  19 
 A 4-nitrophenol standard curve was made by measuring the absorbance at 405 nm 20 
(Abs405) of 0, 4, 8, 12, 16, 20 and 24 nmol of 4-nitrophenol per well in 300 µl of phosphate 21 
buffer, pH 11.4. The KM and Vmax catalytic constants were calculated at pH 9.0 in 22 
50 mM glycine buffer at 22°C in the presence of 0.01 to 50 mM pNP-fucose. The inhibitory 23 
effect of fucose and deoxyfuconojirimycin (DFJ) on the KM and Vmax of the enzyme were 24 
assayed in the same way in the presence of 0.25 mM fucose and 0.1 µM DFJ, respectively.28 25 
Readings were performed using an Infinite 200 plate reader (TECAN) and catalytic constants 26 
17 
 
were calculated with the Sigma Plot 12, Systat Software. 1 
 2 
Substrate specificity of rTfFuc1. For the determination of enzyme linkage specificity, a set 3 
of commercially available fucosylated substrates (2-fucosyllactose and 3-fucosyllactose from 4 
Dextra laboratories; H-Trisaccharide, Lewis A trisaccharide, Fuc-g-(1,4)-Gal and Fuc-g-(1,6)-5 
GlcNAc, all from Carbosynth) (Fig. 3) were incubated with the enzyme and reaction mixtures 6 
were analysed by HPAEC using an ICS3000 chromatographic system (Dionex, Thermo 7 
Fisher) on a CarboPac PA-1 column. Incubations were made overnight at 37°C in a total 8 
volume of 100 µl by mixing 0.34 µM of enzyme with 0.5 mM of substrate in 50 mM glycine 9 
buffer, pH 9.0. In order to minimize the effect of the buffer, the reaction volume was then 10 
diluted with 400 µl of Milli-Q water and the enzyme was removed using an Amicon 3 kDa 11 
cut-off spin column (Millipore). Twenty-five microliters of this flow through was then applied 12 
to the CarboPacPA-1 column using full-loop injection. 13 
 In order to obtain reliable activity values, the K-FUCOSE kit (Megazyme) was 14 
adapted to suit requirements. In a total volume of 250 µl of 50 mM glycine buffer at pH 9.0, 15 
the substrates 2-fucosyllactose, H-trisaccharide and Fuc-g(1,6)-GlcNAc, were incubated 16 
separately at a concentration of 0.5 mM with 1.83 µl of fucose dehydrogenase (FDH) and 17 
9.15 µl of NADP+ (both as supplied) in a cuvette at 37°C for 10 min. When the reaction had 18 
reached a constant absorbance at 340 nm (Abs340), rTfFuc1 was added to the mixture at a 19 
concentration of 0.34 µM and the formation of NADPH was followed by continuous 20 
measurement of the increase in Abs340. The activity of the enzyme on each substrate was 21 
calculated according to the supplier’s specifications from ∆Abs340/min where the formation of 22 
NADPH was linear over time. The experiment was repeated with different enzyme dilutions 23 
(1:10; 1:100) to prove the reliability of the method. 24 
The ability of the enzyme to cleave fucose residues off more complex natural glycans 25 
and those on branched sugar residues was assayed on the substrates A antigen tetraose type 5 26 
18 
 
(Carbosynth), GnGnF6-peptide, GalFGalF, and an N-glycan derived from Crassostrea 1 
virginica (Eastern oyster) haemocyte treated with chicken liver g-N-acetylgalactosaminidase 2 
and bovine く-galactosidase (both from Sigma) to reveal the underlying H epitope presenting a 3 
terminal g(1,2) fucose on an unsubstituted く(1,3)-galactose (i.e., histo blood group antigen H), 4 
referred to here as GalF42 (Fig. 3). Activity on the A antigen substrate was assayed using the 5 
K-FUCOSE kit as described above. For all other substrates, incubations were performed 6 
overnight at 37°C and analysed by MALDI-TOF MS using an Autoflex Speed instrument 7 
(Bruker) in positive ion mode with 6-aza-2-thiothymine (ATT) as matrix. Spectra were 8 
processed with the manufacturer’s software (Bruker Flexanalysis 3.3.80) using the SNAP 9 
algorithm with a signal/noise threshold of 6 for MS (unsmoothed) and then manually 10 
interpreted. 11 
 12 
rTfFuc1 activity on mucin from bovine submaxillary glands. rTfFuc1 was incubated with 13 
bovine submaxillary mucin (Sigma) in combination with the His-tagged recombinant NanH 14 
sialidase (rNanH) from T. forsythia.15 Incubations were performed at 37°C in 50 mM glycine 15 
buffer, pH 9.0, at a final concentration of 0.1 µM of either enzyme, 0.2 mg/ml of mucin and 16 
NADP+ and FDH as described above, in a total volume of 250 µl. rTfFuc1 (and rNanH) was 17 
added to the mixture after an initial 5-min incubation period. The release of fucose (∆Abs340) 18 
was followed over 10 min and calculated according to the supplier’s specifications from 19 
∆Abs340/min where the formation of NADPH was linear over time. 20 
 21 
Presence of TfFuc1 in T. forsythia membrane, outer membrane and non-membrane 22 
preparations. Cells were harvested by centrifugation from a 4-day-old 100-ml T. forsythia 23 
culture. Separation of cellular fractions was performed as described previously.24 Briefly, 24 
cells were washed once in Tris (2-amino-2-hydroxymethyl-propane-1,3-diol)-buffer, pH 7.5, 25 
sonicated, and cell debris were removed by centrifugation. The collected supernatant was 26 
19 
 
ultracentrifuged (100,000 g, 4°C, 40 min) to separate the whole membrane fraction (pellet) 1 
from the membrane non-associated fraction (cytoplasm and periplasm, supernatant). The 2 
pellet was resuspended in 2% (w/v) N-lauroylsarcosine (Sigma) in Tris buffer and mixed. 3 
After incubation (2 h, 25°C), the outer membrane fraction (OM) was collected by 4 
centrifugation (100,000 g, 4°C, 40 min) and the pellet was resuspended in Tris buffer. The 5 
protein content was determined in each fraction by the Bradford method (Bio-Rad).43 A total 6 
of 20 µg of protein from the OM and non-membrane associated fractions and 400 µg of the 7 
membrane fraction was loaded onto an SDS-PAGE gel and ran as described above. The 8 
presence of TfFuc1 in each fraction was determined by Western immunoblotting. 9 
 10 
Microtiter assays of Hoechst-stained biofilms. T. forsythia WT and 〉Tffuc1 strains were 11 
compared in respect to the biofilm formation44 on mucin-coated polystyrene microtiter plates 12 
in dependency of the strength of the BHI liquid medium. Biofilm was stained with Hoechst 13 
33258 Fluorescent Stain (Thermo Scientific). Details are described in the Supplementary 14 
Information. 15 
 16 
Attachment and invasion assays. For both attachment and invasion assays, T. forsythia WT 17 
and 〉Tffuc1 strains were incubated with the oral epithelial cell line H357 (CCL17; American 18 
Type Culture Collection) at a multiplicity of infection of 1:100, as described previously.45 19 
Details are described in the Supplementary Information 20 
 21 
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Figure legends 1 
 2 
Figure 1. SDS PAGE (A.) and Western immunoblot (B.) of total cell extracts from T. 3 
forsythia WT (lane 2) and ∆Tffuc1 strains (lane 3) and of the His6-tagged rTfFuc1 as purified 4 
from E. coli (lane 4), used for activity studies and to raise a polyclonal anti-TfFuc1 antiserum. 5 
Western immunoblotting using the anti-TfFuc1 antiserum recognized the protein (~51 kDa) 6 
specifically in the WT strain (lane 2) and indicated absence of the protein in the ∆Tffuc1 strain 7 
(lane 3), proving that the enzyme was effectively knocked-out. In the preparation of rTfFuc 1 8 
(B., lane 4), the polyclonal antiserum recognizes also minor contaminating E. coli proteins not 9 
visible on the SDS-PAGE gel (A., lane 4). Mm; PageRuler Plus prestained protein ladder 10 
(Thermo Scientific). 11 
 12 
Figure 2. pH profile of rTfFuc1 using 4-nitrophenyl-α-L-fucopyranoside (pNP-fucose) as a 13 
substrate. Activity was measured as the increase in Abs405 due to the released 4-nitrophenol 14 
product. Citrate/phosphate buffer (0.1 M) was used to assay the pH range from 3-8, 50 mM 15 
glycine buffer was used for the pH range from 8-10.25. 16 
 17 
Figure 3. Fucosylated substrates used in this study. The structures are depicted according to 18 
the symbolic nomenclature of the Consortium for Functional Glycomics 19 
(http://www.functionalglycomics.org/static/consortium/Nomenclature.shtml). 20 
 21 
Figure 4. rTfFuc1 activity on standard fucosylated substrates after overnight incubation as 22 
determined by HPAEC. Blue lines represent samples which were incubated in absence of 23 
rTfFuc1 (substrate standard) and red lines represent samples incubated in the presence of 24 
rTfFuc1. Cleavage of the substrates was determined by the appearance of a fucose peak, as 25 
determined by the retention time of the standard monosaccharide. 26 
27 
 
Figure 5. Cleavage of natural g(1,2) fucosylated glycans by rTfFuc1. Cleavage of fucose 1 
from a large N-glycan substrate was monitored by MALDI-TOF MS spectra after overnight 2 
incubation; the conversion of the m/z 1703 glycan (GalF) to one of m/z 1557 (∆m/z 146) is 3 
indicative of the loss of fucose. The structures of the substrate and product are depicted 4 
according to the symbolic nomenclature of the Consortium for Functional Glycomics. 5 
 6 
Figure 6. rTfFuc1 was incubated with mucin from bovine submaxillary glands and the release 7 
of fucose was measured with the K-FUCOSE kit. When incubations were performed in 8 
conjunction with the rNanH sialidase, a slow steady increase in the Abs340 was observed. The 9 
activity was calculated over a period of 300 s where the data points fitted a linear regression 10 
with an r2 of 0.98. No activity could be detected, when rTfFuc1 was incubated alone with the 11 
mucin. The ∆Abs340 lead to an irregular data set with a very low r2 value of 0.4. 12 
 13 
Figure 7. Presence of TfFuc1 in cell fractions of T. forsythia WT. A. SDS-PAGE analysis of 14 
the outer membrane fraction (OM) (1), membrane fraction (2) and non-membrane associated 15 
fraction (3) showed good separation between the fractions, as the S-layer bands were very 16 
prominent in the OM but not in the membrane and non-membrane associated fractions. 17 
Protein loaded was 20 µg of the OM and non-membrane associated fractions and 400 µg of 18 
the membrane fraction. Protein visualization was by CBB. B. Western immunoblot using anti-19 
TfFuc1 antiserum showed the TfFuc1 fucosidase in the non-membrane associated fraction 20 
comprising both the cytoplasmic and periplasmic content. Mm; PageRuler Plus prestained 21 
protein ladder (Thermo Scientific). 22 
  23 
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Table 1. rfFuc1 activity on 4-nitrophenyl-g-L-fucopyranoside (pNP-fucose). Catalytic 1 
constants KM and Vmax and the inhibitory effect of DFJ and L-fucose were measured using the 2 
colorimetric substrate pNP-fucose within a concentration range from 0.01 to 50 mM at 22°C 3 
in glycine buffer at pH 9.0 4 
 5 
Substrate* Inhibitor KM (mM) Vmax (U/mg)** 
pNp-fucose None 0.67 (±0.2) 20.4 (±0.8) 
pNp-fucose 0.1 µM DFJ*** 28.3 (±3.7) 28.1 (±2.4) 
pNp-fucose 0.25 mM Fucose 16.5 (±4.7) 28.6 (±4.4) 
 6 
*4-nitrophenyl-g-L-fucopyranoside 7 






Table 2. rTfFuc1 activity on standard fucosylated substrates. Cleavage was determined by HPAEC after overnight incubations with rTfFuc1 (see 












*µmol/min/mg of enzyme 
  






2-Fucosyllactose g-L-Fuc-1,2-く-D-Gal-1,4-D-Glc g(1,2) Yes 0.8 
3-Fucosyllactose く-D-Gal-1,4(g-L-Fuc-1,3)-D-Glc g(1,3) No - 
H-trisaccharide g-L-Fuc-1,2-く-D-Gal-1,3-く-D-GlcNAc g(1,2) Yes 0.6 
Lewis A trisaccharide く-D-Gal-1,3(g-L-Fuc-1,4)-く-D-GlcNAc g(1,4) No - 
Fuc(1,6)GlcNAc g-L-Fuc-1,6-く-D-GlcNAc g(1,6) Yes 0.35 
Fuc(1,4)Gal g-L-Fuc-1,4-く-D-Gal g(1,4) No - 
A antigen tetraose く-GalNAc-1,3(g-L-Fuc-1,2)-く-D-Gal-1,4-D-Glc g(1,2) No - 
30 
 
Table 3. Bacterial strains and plasmids used in this study 
Strain or plasmid Genotype and/or relevant characteristic(s) Source 
Escherichia coli DH5g 
F- 80dlacZ M15 (lacZYA-argF)U169 deoR recA1 endA1 
hsdR17 (rK-mK-) phoA supE44 thi-1 gyrA96 relA1- 
Invitrogen 
Escherichia coli BL21 (DE) F-, ompT, hsdS (rB-mB-), gal, dcm (DE3) Invitrogen 
Tannerella forsythia ATCC 43037 Wild-type isolate American Type Culture Collection, USA 
T. forsythia ∆Tffuc1 T. forsythia knockout of the Tffuc1 gene; Ermr This study 
pET-22b (+) Expression vector with a His6-tag, Ampr Novagen 





Table 4. Oligonucleotide primers used for PCR amplification reactionsa 














a. Artificial restriction sites are underlined. Lowercase letters indicate artificially introduced bases to improve restriction enzyme cutting. 
In italics are the overlap sequences complementary to ermF-ermAM. In bold are the overlap sequences complementary to the BFO_2737 flanking 
regions. 










































































































































































Figure 7. of Megson et al. 
Table 1. rfFuc1 activity on 4-nitrophenyl-g-L-fucopyranoside (pNP-fucose). Catalytic 
constants KM and Vmax and the inhibitory effect of DFJ and L-fucose were measured using the 
colorimetric substrate pNP-fucose within a concentration range from 0.01 to 50 mM at 22°C 
in glycine buffer at pH 9.0 
 
Substrate* Inhibitor KM (mM) Vmax (U/mg)** 
pNp-fucose None 0.67 (±0.2) 20.4 (±0.8) 
pNp-fucose 0.1 µM DFJ*** 28.3 (±3.7) 28.1 (±2.4) 
pNp-fucose 0.25 mM Fucose 16.5 (±4.7) 28.6 (±4.4) 
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2-Fucosyllactose g-L-Fuc-1,2-く-D-Gal-1,4-D-Glc g(1,2) Yes 0.8 
3-Fucosyllactose く-D-Gal-1,4(g-L-Fuc-1,3)-D-Glc g(1,3) No - 
H-trisaccharide g-L-Fuc-1,2-く-D-Gal-1,3-く-D-GlcNAc g(1,2) Yes 0.6 
Lewis A trisaccharide く-D-Gal-1,3(g-L-Fuc-1,4)-く-D-GlcNAc g(1,4) No - 
Fuc(1,6)GlcNAc g-L-Fuc-1,6-く-D-GlcNAc g(1,6) Yes 0.35 
Fuc(1,4)Gal g-L-Fuc-1,4-く-D-Gal g(1,4) No - 
A antigen tetraose く-GalNAc-1,3(g-L-Fuc-1,2)-く-D-Gal-1,4-D-Glc g(1,2) No - 
Table 3. Bacterial strains and plasmids used in this study 
Strain or plasmid Genotype and/or relevant characteristic(s) Source 
Escherichia coli DH5g 
F- 80dlacZ M15 (lacZYA-argF)U169 deoR recA1 endA1 
hsdR17 (rK-mK-) phoA supE44 thi-1 gyrA96 relA1- 
Invitrogen 
Escherichia coli BL21 (DE) F-, ompT, hsdS (rB-mB-), gal, dcm (DE3) Invitrogen 
Tannerella forsythia ATCC 43037 Wild-type isolate American Type Culture Collection, USA 
T. forsythia ∆Tffuc1 T. forsythia knockout of the Tffuc1 gene; Ermr This study 
pET-22b (+) Expression vector with a His6-tag, Ampr Novagen 
pJET1.2-Tffuc1_ko  pJET1.2 carrying the Tffuc1_ermF-AM knockout cassette This study 
 
 
Table 4. Oligonucleotide primers used for PCR amplification reactionsa 














a. Artificial restriction sites are underlined. Lowercase letters indicate artificially introduced bases to improve restriction enzyme cutting. 
In italics are the overlap sequences complementary to ermF-ermAM. In bold are the overlap sequences complementary to the BFO_2737 flanking 
regions. 















Attachment and invasion assays. The H357 oral epithelial cell line (CCL17; American Type 
Culture Collection) was maintained in Dulbecco’s modified Eagle medium (DMEM; Gibco) 
supplemented with 10% fetal bovine serum and L-glutamine. The cultures were incubated at 
37°C under 5% CO2. H357 cells were grown to near-confluence (90 to 95%) for the assays.  
 For both attachment and invasion assays, T. forsythia WT and 〉Tffuc1 strains were 
incubated with H357 cells at a multiplicity of infection of 100, as described previously.1 
Briefly, for attachment assays, epithelial cell monolayers incubated with bacteria for 1.5 h 
were washed three times with sterile PBS, epithelial cell-associated bacteria were retrieved by 
lysing monolayers by addition of distilled water before physical disruption by scraping, and 
bacteria were plated for counting. For invasion assays, epithelial cell monolayers incubated 
with bacteria were washed with DMEM and then treated with metronidazole (200 µg/ml) for 
1 h to kill external bacteria. The monolayers were then washed with PBS and were lysed as 
above to allow intracellular bacteria counting. 
 
Microtiter assays of Hoechst-stained biofilms. Tannerella forsythia WT and 〉Tffuc1 
biofilms were grown essentially as previously described in both full-strength and half-strength 
liquid BHI medium.2 Before starting the bacterial cell culture, a 0.5-mg/ml solution of mucin 
from bovine submaxillary gland (Sigma) was prepared in 0.1 M sodium citrate buffer, pH 4.5, 
containing 0.1 M NaCl, added to non-treated polystyrene 24 well-plates (500 µl/well; Thermo 
Scientific) and incubated overnight at 37°C. On the next day, the mucin solution was removed 
completely and strains were inoculated at an OD600 ~0.05 in full-strength BHI medium 
supplemented with horse serum and N-acetylmuramic acid or in mediu  diluted 1:2 with 
2 
 
phosphate-buffered saline (PBS), yielding half-strength medium. In both cases, the medium 
was also supplemented with gentamycin (50 µg/ml) and gentamycin/erythromycin (50 µg/ml, 
10 µg/ml) for WT and 〉Tffuc1, respectively. Triplicates were made for each condition and a 
fourth well served for measurement of total growth (OD600). The plates were incubated 
anaerobically for 48 h at 37°C; subsequently, the supernatant was removed and the biofilm 
was washed once with 800 µl PBS before adding 1 ml/well of 10 µg/ml Hoechst 33258 
Fluorescent Stain (Thermo Scientific) in PBS.3 The biofilm was then removed from the 
bottom of the well using vigorous pipetting and the plates were left in the dark on a shaker for 
45 min. 100 µl from each well was placed in a black 96-well-plate with a flat optical bottom 
(Thermo Scientific) for fluorescence intensity readings using excitation/emission filters of 
360(35)/485(20) in an Infinite 200 plate reader (TECAN). The fluorescence intensity was 
corrected by the total OD600 reached by each strain. 
 
Immunofluorescence microscopy of T. forsythia cells using TfFuc1-specific polyclonal 
antiserum. The surface localization of TfFuc1 was investigated by immunofluorescence 
staining of T. forsythia WT as described elsewhere.4 
 Cells were grown until the late-exponential phase (OD600 ~1.0), washed with PBS 
and adsorbed on a glass slide for 2 h. All procedures were performed at 22°C, if not stated 
otherwise. Cells were washed twice with PBS and fixed for 30 min at -20°C in 70% (v/v) 
ethanol in PBS. After two washing steps with PBS, cells were incubated in blocking buffer 
[10%, (w/v) bovine serum albumin (Sigma) in PBS] for 1 h, followed by incubation in 
blocking buffer containing TfFuc1-specific polyclonal antiserum or pre-immune serum (1:10-
dilution) for 1 h, washed once with blocking buffer and twice with PBS, and subsequently 
incubated in blocking buffer containing goat anti-mouse IgG (1:100) conjugated to FITC 
(Sigma-Aldrich) for 2 h. The cells were washed once with blocking buffer and twice with 
PBS to remove unbound antibodies. One drop of 50% (v/v) glycerol in PBS was added onto 
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the cells and a coverslip was mounted. Confocal laser scanning microscopy analysis was 
performed using a Leica TCS SP5 II system. Images were taken with a 63.0 x 1.40 oil-
immersion objective. Immunofluorescence-stained bacterial cells were excited at 488 nm 
using an argon laser and detected at an emission bandwidth of 500-595 nm. Images were 
acquired and processed with Leica LAS AF software. 
 
Results and Discussion 
 
Attachment and invasion assays. The effect of the Tffuc1 mutation on the ability of T. 
forsythia to interact with and invade human oral epithelial cells was tested using an antibiotic 
protection assay on the oral epithelial cell line H357. Results are shown as percentage of the 
bacterial cells recovered compared to a viability control run in parallel during the course of 
the whole experiment. 
The data shows no significant difference in invasion between WT and fuc strains 
(Fig. S1). In addition, we compared the ability of the strains to attach to the epithelial cell line 
and again, no significant difference could be highlighted between the two (not shown), thus, 
indicating that TfFuc1 most likely does not play a role in direct human-pathogen interactions. 
 
Microtiter assays of Hoechst-stained biofilms. T. forsythia WT and the Tffuc1 mutant 
were cultured anaerobically for 2 d in full-strength and half-strength mediu  in 24-well 
microtiter plates coated with mucin,2 which is needed to promote biofilm formation as the 
presence of terminal sialic acid is an important factor allowing for T. forsythia surface 
attachment and biofilm growth.5 Biofilm formation was evaluated by measuring the 
fluorescence intensity of the Hoechst-stained biofilm (Fig. S2A). As the different strains 
presented a different growth in the different conditions tested, the fluorescence intensity was 
corrected by the total OD600 reached in each experiment. 
4 
 
 The WT strain increased its biofilm formation 1.4-fold as the strength of the 
medium was decreased to half by diluting with PBS. This indicates that biofilm formation is 
quite sensitive to changes of the medium strength, potentially indicating a degree of starvation 
(Fig. S2A). 
 In all experiments, the 〉Tffuc1 had a higher biofilm formation phenotype than the 
WT strain, but how large the difference was depended largely on the strength of the growth 
medium. In full-strength BHI medium, the increased biofilm formation for the 〉fuc mutant 
was 1.2-fold that of the WT. In the case of half-strength medium, the difference became more 
prominent as 〉fuc presented a 1.5-fold increase (Fig. S2B). These results could indirectly 
indicate a difference between the strains in their ability to utilize and scavenge components in 
the medium but it is currently not clear whether the observed phenotype reflects solely the 
loss of Tffuc1 as no gene complementation assay was performed. We, therefore, conclude that 
the loss of the gene Tffuc1 does not lead to a decreased biofilm formation indicating no direct 
role of the protein in the interaction of T. forsythia with the mucin-coated surface. 
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Figure S1. Cell invasion assays. The effect of the Tffuc1 mutation on the ability of T. 
forsythia to interact and invade human oral epithelial cells was tested on the oral epithelial 
cell line H357. The combined results from three experimental repeats are shown as a 
percentage of the bacterial cells recovered compared to a viability control. W, T. forsythia 
























Figure S2. Microtiter assays of Hoechst-stained biofilms. A. The WT strain increased its 
biofilm formation on a mucin-coated surface as the strength of the medium was decreased to 
half that of the original broth. B. The difference in biofilm formation between the WT and the 
〉Tffuc1 depends largely on the strength of the medium. W, T. forsythia wild-type; F, 
T. forsythia Tffuc1. 


